CRSP
CRISPR Therapeutics
CRISPR-Cas9 gene editing therapies
$56.18
90d: -9.0%
Updated 31 May 2026, 07:59 UTC · ← Biomedical Therapeutics
👁️
Showcase mode. This page will require a Premium subscription (£70/month) once subscriptions launch. Full company intelligence is shown here so you can see exactly what you'll get. Request early access →
🔒
Premium Intelligence — Previewing Now
This company intelligence brief will be behind the Premium tier (£70/month) when subscriptions launch. You're seeing a full preview below.
What Premium includes
✓ Full intelligence brief for all 42+ tracked companies
✓ AI interrogation of 56,000+ article corpus
✓ Real-time Telegram alerts when CRSP is flagged
✓ Swap proposals with full signal reasoning
✓ Private market watchlist access
Request Early Access → ← Back to Biomedical Therapeutics